Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
USA
/
Corporate bonds
/
RVNC5133129
Revance Therapeutics, Inc. 1.75% 15-FEB-2027
RVNC5133129
FINRA
RVNC5133129
FINRA
RVNC5133129
FINRA
RVNC5133129
FINRA
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
News
RVNC5133129
chart
Full chart
1 day
5 days
1 month
6 months
Year to date
1 year
5 years
All time
Key terms
Outstanding amount
287.50 M
USD
Face value
1,000.00
USD
Minimum denomination
1,000.00
USD
Coupon
1.75% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
4.17%
Maturity date
Feb 15, 2027
Term to maturity
2 years
About Revance Therapeutics, Inc. 1.75% 15-FEB-2027
Issuer
Revance Therapeutics, Inc.
Sector
Health Technology
Issue date
Feb 17, 2021
Home page
revance.com
FIGI
BBG00RQ22273
RVNC5133129
analysis
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.
Start trial
RVNC5133129
news